Cancer Immunotherapy IMCgp100 Shows Early Positive Results in Advanced Uveal Melanoma – Immuno-Oncology News
Immuno-Oncology News |
Cancer Immunotherapy IMCgp100 Shows Early Positive Results in Advanced Uveal Melanoma
Immuno-Oncology News In an attempt to develop therapies for melanoma and uveal melanoma patients, Immunocore developed a new immunotherapy that targets the gp100 molecule — found mostly on melanoma cells — while activating tumor-killing immune cells. To date, the … |
